Exemestane 25mg Tablet is a potent aromatase inhibitor prescribed primarily for the treatment of hormone receptor-positive breast cancer in postmenopausal women. This medication works by irreversibly binding to and inactivating the aromatase enzyme, which is responsible for converting androgens into estrogens. By lowering estrogen levels, Exemestane 25mg effectively slows or stops the growth of estrogen-dependent breast cancer cells. It is commonly used as adjuvant therapy following surgery or radiation, or for advanced breast cancer cases where prior anti-estrogen therapy has failed. The tablet form ensures precise dosage and easy administration, making it a reliable option for healthcare providers managing breast cancer treatment protocols. Exemestane 25mg is essential in oncological pharmacotherapy and is frequently used in combination with other therapies for optimized patient outcomes.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Exemestane 25mg |
| Therapeutic Use | Treatment of hormone receptor-positive breast cancer |
| Mechanism of Action | Irreversible aromatase inhibitor reducing estrogen synthesis |
| Dosage Form | Oral tablet |
| Target Patient Group | Postmenopausal women with breast cancer |
| Usage | Adjuvant therapy or treatment of advanced breast cancer |
| Administration Route | Oral |
| Packaging | Blister packs or bottles (varies by supplier) |
| Storage | Store below 30°C, protect from moisture and light |
| Attributes | Description |
|---|---|
| Dosage Strength | 25 mg per tablet |
| Tablet Color | White to off-white |
| Tablet Shape | Round |
| Excipients | Includes fillers, binders, and tableting agents safe for oral use |
| Shelf Life | Typically 24 months from manufacture |
| Manufacturer Compliance | Manufactured under GMP certified facilities |
| Regulatory Approval | Approved for use in India and other regulated markets |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Exemestane 25mg is typically indicated for use in postmenopausal women with hormone receptor-positive breast cancer; its safety and efficacy in premenopausal women require additional hormonal suppression therapy.
The standard dosage for Exemestane is one 25mg tablet taken orally once daily after a meal, but specific treatment schedules should be determined by an oncologist.
Exemestane is usually employed after other anti-estrogen therapies such as tamoxifen have been tried, or as adjuvant therapy post-surgery.
Yes, Exemestane tablets should be stored below 30°C, protected from moisture and light to maintain efficacy.
Yes, this product is approved and manufactured under GMP standards complying with Indian drug regulatory requirements.
Country Of Origin: India
Exemestane is used in the treatment of breast cancer
